Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus

NCT02455089 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT02455089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02455089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
February 28, 2019
Enrollment
143 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lupus erythematosus